Effects of Inhaled L-Arginine Administration in A Murine Model of Acute Asthma
-
Zeynep Arikan-Ayyildiz
,
Meral Karaman
,
Fatih Firinci
,
Muge Kiray
,
Alper Bagriyanik
,
Osman Yilmaz
,
Nevin Uzuner
,
Ozkan Karaman
Abstract
Increased arginase activity in the airways decreases L-arginine and causes deficiency of bronchodilating and anti-inflammatory nitric oxide (NO) in asthma. As, it is suggested that L-arginine may have therapeutic potential in asthma treatment, we aimed to investigate the effects of inhaled L-arginine on oxygen saturation (SaO₂) and airway histology in a murine model of acute asthma. Twenty eight BALB/c mice were divided into four groups; I, II, III and IV (control). All groups except the control were sensitized and challenged with ovalbumin. After establishement of acute asthma attack by metacholine administration, the mice were treated with inhaled L-arginine (Group I), saline (Group II) and budesonide (Group III), respectively. SaO₂was measured by pulse oximeter just before and 5 min after methacholine. A third measurement of SaO₂was also obtained 15 min after drug administration in these study groups. Inflammation in the lung tissues of the sacrificed animals were scored to determine the effects of the study drugs. The number of eosinophils in bronchoalveolar lavage (BAL) was determined. The results indicated that inflammatory scores significantly improved in groups receiving study drugs when compared with placebo and L-arginine was similar in decreasing scores when compared with budesonide. SaO₂had a tendency to increase after L-arginine administration after acute asthma attack and this increase was statistically significant (p=0.043). Eosinophilia in BAL significantly reduced in group receiving L-arginine when compared with placebo (p<0.05). Thus in this study we demonstrated that L-arginine improved SaO₂and inflammatory scores in an acute model of asthma.
1. Keller AC, Rodriguez D, Russo M. Nitric oxide paradox in asthma. Mem Inst Oswaldo Cruz 2005; 100(suppl 1):19-23.
2. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 2004; 170(2):148-53.
3. Mabalirajan U, Ahmad T, Leishangthem GD, Joseph DA, Dinda AK, Agrawal A, et al. Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. J Allergy Clin Immunol 2010; 125(3):626-35.
4. Maarsingh H, Zuidhof AB, Bos IS, van Duin M, Boucher JL, Zaagsma J, et al. Arginase inhibiton protects against allergen-induced airway obstruction, hyperresponsiveness and inflammation. Am J Respir Crit Care Med 2008;178(6):565-73.
5. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004; 84(3):731-65.
6. Maarsingh H, Zaagsma J, Meurs H. Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol 2009; 158(3):652-64.
7. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 1997; 94(13):6954-8.
8. Xia Y, Roman LJ, Masters BS, Zweier JL. Inducible nitric- oxide synthase generates superoxide from the reductase domain. J Biol Chem 1998; 273(35):22635-9.
9. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998; 53(10):849-56.
10. Karaman M, Arikan-Ayyildiz Z, Firinci F, Kiray M, Bagriyanik A, Yılmaz O, et al. Effects of curcumin on lung histology and fungal burden in a mouse model of chronic asthma and oropharyngeal candidiasis. Arch Med Res 2011; 42(2):79-87.
11. Uzuner N, Kavukcu S, Yilmaz O, Ozkal S, Islekel H, Karaman O, et al. The role of L-carnitine in treatment of a murine model of asthma. Acta Med Okayama 2002;56(6):295-301.
12. Maarsingh H, Zuidhof AB, Bos IS, et al. Arginase inhibiton protects against allergen- induced airway obstruction, hyperresponsiveness and inflammation. Am J Respir Crit Care Med 2008; 178(6): 565-73.
13. Gong PH, Gao ZC, Hu P, Xu Y. Investigation of the measurement of murine airway hyperresponsiveness and the therapeutic effects of budesonide on ovalbumin sensitized and challenged mice. Chin Med J (Engl) 2005;118(23):1959-64.
14. Morris CR. Arginine and asthma. Nestle Nutr Inst Workshop Ser 2013; 77:1-15.
15. Appleton J. Arginine: clinical potential of a semi-essential amino. Altern Med Rev 2002; 7(6):512-22.
16. Sapienza MA, Khaeitonov SA, Horvath I, Chung KF, Barnes PJ. Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax 1998;53(3):173-5.
17. Abuzayan I, Turner SW. Changes in exhaled nitric oxide after ingestion of L-arginine in children: A pilot study. Pediatr Pulmonol 2010; 45(3):236-40.
18. Takano H, Lim HB, Miyabara Y, Ichinose T, Yoshikawa T, Sagai M. Oral admisitration of L-arginine potentiates allergen induced airway inflammation and expression of interleukin-5 in mice. J Pharmacol Exp Ther 1998;286(2):767-71.
19. Qadi-Nassar BA, Laurent-Bichon F, Portet K, Tramini P, Arnoux B, Michel A. Effects of L-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responiseveness of sensitized BP2 mice. Fundam Clin Pharmacol 2007; 21(6):611-20.
20.Verhoeven D, Teijaro J, Farber DL. Pulse oximetry accurately predicts lung pathology and the immune response during influenza infection. Virology 2009;390(2):151-6.
21. Early MA, Lishnevsky M, Gilchrist JM, Higgins DM, Orme IM, Muller WA, et al. Non-invasive diagnosis of early pulmonary disease in PECAM-deficient mice using infrared pulse oximetry. Exp Mol Pathol 2009; 87(2):152-8.
| Files | ||
| Issue | Vol 13, No 5 (2014) | |
| Section | Articles | |
| Keywords | ||
| Acute asthma Inflammation L-arginine Murine model SaO2 | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
